Moderna
MRNA
#290
Rank
ยฃ60.31 B
Marketcap
ยฃ149.06
Share price
-2.17%
Change (1 day)
706.64%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): -ยฃ6.00

According to Moderna 's latest financial reports the company's current EPS (TTM) is -ยฃ6.11. In 2025 the company made an earnings per share (EPS) of -ยฃ5.56 an increase over its 2024 EPS that were of -ยฃ7.09.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ6.007.97%
2025-ยฃ5.56-21.66%
2024-ยฃ7.09-25.04%
2023-ยฃ9.46-158.62%
2022ยฃ16.14-30.25%
2021ยฃ23.15-1660.82%
2020-ยฃ1.4825.32%
2019-ยฃ1.1836.87%
2018-ยฃ0.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.11-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ4.01-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ0.76-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ0.56-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.55-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ15.14-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ2.55-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA